ITP
A Phase 2a, Open-Label, Multicenter Study of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders. Study n. INCA000585-201.
- Details
ClinicalTrials.gov ID:
NCT07104565
Diagnosis Type:
NA
USOR Number:
- Address
,
P: